 | |
 Headquarters in Ahmedabad | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1951 |
| Founder | Indravadan Modi |
| Headquarters | , India |
Key people | Rajiv Modi (Chairman and Managing Director) |
| Products | APIs, generic drugs |
| Services | |
| Revenue |  ₹3,675 crore (US$430 million) (FY23)[1] |
 ₹−10 crore (US$−1.2 million) (FY23)[1] | |
Number of employees | 8,000 |
| Subsidiaries | IRM Ltd |
| Website | www |
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.[2]
History
[edit]In 1951 Indravadan A Modi had quit his job as a chemist in a Mumbai firm to start Cadila Laboratories with childhood friend Ramanbhai Patel. The company started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation.[3]
The Modi and Patel families decided to split the business in 1995, and two entities were formed: Cadila Pharmaceuticals Ltd (owned and controlled by Indravadan Modi and his son Rajiv Modi) and Cadila Healthcare (owned by Ramanbhai Patel and his son Pankaj Patel family).[3]
In 2019, Cadila Pharmaceuticals formed a partnership with Norwegian start-up, Serca Pharmaceuticals to develop new treatment for heart patients.[4]
In November 2023, the company opened an active pharmaceutical ingredient (API) plant in Dahej, in Gujarat's Bharuch district. The facility was built with an investment of ₹200 crore, and is equipped with distributed control system (DCS) automation technology. [5]
Operations
[edit]Cadila Pharmaceuticals has its formulation manufacturing facilities at Dholka, Gujarat (India); Samba, Jammu (India) and at Addis Ababa (Ethiopia) and 2 API manufacturing facilities are located at Ankleshwar, Gujarat. The manufacturing facility at Dholka and the API unit at Ankleshwar in Gujarat are USFDA-certified; the overseas manufacturing facility at Ethiopia is the WHO - cGMP compliant facility.[6]
Controversies
[edit]Company
[edit]In 2014, a cautionary notice appeared on the US Food and Drug Administration (FDA) website, highlighting substantial manufacturing practice discrepancies discovered by inspectors in March at Cadila Pharmaceuticals' Ankleshwar facility in Gujarat.[7] This incident marked one among several Indian pharmaceutical companies receiving regulatory warnings from the FDA, indicating increased scrutiny on generic drugmakers.[8] A similar kind of notices were again issued in 2016[9] and 2019.[10]
Management
[edit]In 2018, the chairman of the company, Rajiv Modi, went through a widely publicized and contentious divorce with his wife, Monica, who comes from a prominent Mumbai-based business family of Garware. At that time, Modi transferred ₹200 crore (US$24 million) to Monica, who relinquished her rights, while custody of their son was awarded to Modi.[11][12]
In December 2023, Gujarat Police complied with a Gujarat High Court order, initiating a case against Rajiv Modi.[13] The case involves accusations of rape, assault, and intentional insult by a Bulgarian woman employed as a flight attendant and personal assistant at the company. She reported multiple instances of sexual harassment from February to March 2023, stating that she was terminated in April 2023 after resisting Modi's alleged “illicit demands”.[14][15]
References
[edit]- ^ a b "Cadila Pharmaceuticals Limited". Crediwatch. Retrieved 18 December 2023.
- ^ "Cadila Pharma to expand and upgrade its existing facilities in Gujarat". BusinessLine. 22 March 2023. Retrieved 11 September 2023.
- ^ a b Das, Sohini (28 January 2014). "Carrying the legacy forward: Rajiv Modi" – via Business Standard.
- ^ "Cadila Pharma inks pact with Norwegian start-up to develop new treatment for heart patients". @businessline. 10 January 2019. Retrieved 11 January 2019.
- ^ "Business today". 27 November 2023.
- ^ Financial Express 28 January 2013
- ^ Mishra, Digbijay; Das, Sohini (13 November 2014). "US FDA scolds Cadila Pharma over manufacturing practice in Gujrat plant". Retrieved 6 January 2024.
- ^ "FDA warns Cadila Pharma over drug production processes". Reuters. 12 November 2014. Retrieved 6 January 2023.
- ^ RAJAGOPAL, DIVYA (1 January 2016). "Cadila gets US FDA warning for violating standards at Moraiya and Ahmedabad plants". The Economic Times. ISSN 0013-0389. Retrieved 6 January 2024.
- ^ Research, Center for Drug Evaluation and (28 November 2022). "Cadila Healthcare Limited - 584856 - 10/29/2019". Center for Drug Evaluation and Research. Retrieved 6 January 2024.[dead link]
- ^ "Gujarat: Cadila Pharma owner pays wife Rs 200 crore". The Times of India. 31 October 2018. ISSN 0971-8257. Retrieved 6 January 2024.
- ^ "Cadila Pharmaceuticals boss Rajiv Modi swallows a Rs 200-cr divorce pill". DNA India. Retrieved 6 January 2024.
- ^ Khatri, Dhananjay (24 December 2023). "Gujarat HC orders probe against Cadila Pharma CMD into rape allegations". CNBCTV18. Retrieved 6 January 2024.
- ^ "Cops register FIR against Cadila CMD for rape of Bulgarian woman after Gujarat HC order". The Indian Express. 31 December 2023. Retrieved 6 January 2024.
- ^ PTI. "Gujarat police register rape case against Cadila Pharma CMD after HC order". Deccan Herald. Retrieved 6 January 2024.